Pregnancy After Cardiac Surgery

Area of Science:

• Cardiology
• Maternal-Fetal Medicine
• Cardiac Surgery

Background:

• Pregnancy significantly impacts women with native heart valve disease, increasing risks for both mother and fetus.
• Bioprosthetic valves in pregnancy are associated with structural degeneration and high reoperation rates.
• Mechanical valves during pregnancy elevate risks of maternal complications, including valve thrombosis and mortality.

Purpose of the Study:

• To review and outline appropriate management strategies for pregnant women with valvular heart disease.
• To emphasize the importance of preconception risk estimation and intervention planning.
• To discuss the balance between maternal outcomes and fetal risks in managing cardiac disease during pregnancy.

Main Methods:

• Review of existing literature on valvular heart disease in pregnancy.
• Analysis of risks associated with different types of prosthetic valves during gestation.
• Examination of anticoagulation strategies and their safety profiles in pregnant patients.
• Discussion of integrated risk stratification and algorithmic approaches for preconception counseling.

Main Results:

• Pregnancy poses significant risks for women with native or prosthetic heart valves.
• Both bioprosthetic and mechanical valves present distinct complications during pregnancy.
• Cardiac surgery during pregnancy carries substantial fetal risk.
• No anticoagulant regimen is entirely risk-free for use during pregnancy.

Conclusions:

• Comprehensive risk assessment and individualized management plans are crucial for pregnant women with heart valve disease.
• Preconception counseling, including prosthetic device choice and anticoagulation strategy, is vital.
• Management requires a multidisciplinary approach, balancing maternal health and fetal well-being.
• Further research is needed to optimize safety and efficacy of interventions and anticoagulation during pregnancy.